Alternatives to CellType

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI-powered platform accelerating biological research and drug discovery.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Personalized computational drug screening for rare diseases using patient genetics and automation.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

A global oncology company developing and commercializing innovative cancer treatments.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Mapping cell-cell communication at scale in human tissue.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Discovers autoimmune drugs by mining proteins from parasites, viruses, and ticks with AI.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered drug discovery and development platform for biologics.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Drug discovery platform focused on developing therapeutics for age-related diseases.